 |
|
Novel biomarkers for the management of chronic hepatitis B
Takako Inoue, Yasuhito Tanaka
Clin Mol Hepatol. 2020;26(3):261-279. Published online 2020 Jun 15 DOI: https://doi.org/10.3350/cmh.2020.0032
|
|
Citations to this article as recorded by
 AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection
Xiaohuan Lai, Haiyan Chen, Xiaofeng Dong, Guanlin Zhou, Dong Liang, Fei Xu, Hongxia Liu, Yingmin Luo, Hui Liu, Shaogui Wan
European Journal of Gastroenterology & Hepatology.2024; 36(3): 338. CrossRef The significance of m6A RNA methylation regulators in diagnosis and subtype classification of HBV-related hepatocellular carcinoma
Qijuan Zang, Yalin Ju, Siyi Liu, Shaobo Wu, Chengbin Zhu, Liangru Liu, Weicheng Xu, Yingli He
Human Cell.2024; 37(3): 752. CrossRef Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
Jian Wang, Li Zhu, Shaoqiu Zhang, Zhiyi Zhang, Tao Fan, Fei Cao, Ye Xiong, Yifan Pan, Yuanyuan Li, Chao Jiang, Shengxia Yin, Xin Tong, Yali Xiong, Juan Xia, Xiaomin Yan, Yong Liu, Xingxiang Liu, Yuxin Chen, Jie Li, Chuanwu Zhu, Chao Wu, Rui Huang
Emerging Microbes & Infections.2024;[Epub] CrossRef Comparable Mortality Between Asian Patients with Chronic Hepatitis B Under Long-Term Antiviral Therapy vs Matched Control: A Population-Based Study
Byungyoon Yun, Juyeon Oh, Sang Hoon Ahn, Jin-Ha Yoon, Beom Kyung Kim
American Journal of Gastroenterology.2023; 118(6): 1001. CrossRef A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022
Qianqian Zhao, Luhua Liang, Fei Zhai, Guixia Ling, Rongwu Xiang, Xiwei Jiang
Journal of Gastroenterology and Hepatology.2023; 38(3): 359. CrossRef A critique and systematic review of the clinical utility of hepatitis B core-related antigen
Celina Adraneda, Yong Chuan Tan, Ee Jin Yeo, Guan Sen Kew, Atefeh Khakpoor, Seng Gee Lim
Journal of Hepatology.2023; 78(4): 731. CrossRef Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
Clinical and Molecular Hepatology.2023; 29(1): 191. CrossRef New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
Young-Suk Lim
Clinical and Molecular Hepatology.2023; 29(1): 118. CrossRef Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Clinical and Molecular Hepatology.2023; 29(1): 113. CrossRef Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas
Ivana Lazarevic, Ana Banko, Danijela Miljanovic, Maja Cupic
Viruses.2023; 15(2): 373. CrossRef Effects of Entecavir on Serum Hepatitis B Virus-DNA, Interferon-γ, and Pregenomic RNA in Patients with Chronic Hepatitis B Virus Infection
Xuyang Gong, Zhitao Chen, Xiaoxia Zhang, Yi Zheng, Heng Zhang
Hepatitis Monthly.2023;[Epub] CrossRef Research progress on detection methods for hepatitis B virus covalently closed circular DNA
Fenglan Sun, Wei Xia, Yaoling Ouyang
Journal of Viral Hepatitis.2023; 30(5): 366. CrossRef The association of serum immunoglobulin and complement levels and liver fibrosis and inflammation stage in patients with chronic hepatitis B
Mingjian Lian, Qianming Wang, Shidong Chen, Yuanyuan Yang, Guolin Hong
Journal of Viral Hepatitis.2023; 30(5): 437. CrossRef Construction of a Lasso regression-based prediction model for development of cirrhosis in chronic hepatitis B
Ying Li, Ke-Xing Han, Qian Su, Nan Xu, Qin-Xiu Xie, Yu-Feng Gao
World Chinese Journal of Digestology.2023; 31(7): 282. CrossRef The role of different viral biomarkers on the management of chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
Clinical and Molecular Hepatology.2023; 29(2): 263. CrossRef Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, Zhiqiang Xu, Chunyu Chen, Baochen Chong, Xinjun Zhao, Shan Hai, Shuangqing Li, Zhenmei An, Lunzhi Dai
MedComm.2023;[Epub] CrossRef HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
Simona Ruta, Laura Grecu, Diana Iacob, Costin Cernescu, Camelia Sultana
Biomedicines.2023; 11(5): 1306. CrossRef Current and novel modalities for management of chronic hepatitis B infection
Iman Ibrahim Salama, Samia M Sami, Somaia I Salama, Ghada A Abdel-Latif, Fatma A Shaaban, Walaa A Fouad, Aida M Abdelmohsen, Hala M Raslan
World Journal of Hepatology.2023; 15(5): 585. CrossRef Association of genetic polymorphisms in the C19orf66 gene and biochemical indices of HBV infected individuals in Yunnan
Ni Liu, Min Liu, Jun Yang, Shuwei Dong, Ming Yue, Peng Huang, Xueshan Xia, A-Mei Zhang
Frontiers in Cellular and Infection Microbiology.2023;[Epub] CrossRef Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B
Joo Hyun Oh, Yewan Park, Myung Ji Goh, Dong Hyun Sinn, Sang Bong Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
Scientific Reports.2023;[Epub] CrossRef Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association.2023; 122(12): 1238. CrossRef Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study
Heejoon Jang, Su Jong Yu, Hong Ghi Lee, Tae Min Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim
Journal of Korean Medical Science.2023;[Epub] CrossRef Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
Heejin Cho, Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
BMC Gastroenterology.2023;[Epub] CrossRef Value of XGBoost machine learning model for diagnosis of hepatitis B cirrhosis
Ji Li, Ke-Xing Han, Jia-Pei Shen, Wei-Jie Sun, Long Gao, Yu-Feng Gao
World Chinese Journal of Digestology.2023; 31(13): 544. CrossRef The incidence of liver abnormalities is higher in inactive hepatitis B virus carriers with influenza A infection
Liqin Sun, Yong‐Mei Yin, Nan Xiao, Cheng Wang, Xiao‐Guang Li, Jun Wang, Hongzhou Lu
iLABMED.2023; 1(2): 93. CrossRef Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
Ivana Lazarevic, Valentina Svicher, Maja Cupic
Frontiers in Medicine.2023;[Epub] CrossRef Increased liver stiffness promotes hepatitis B progression by impairing innate immunity in CCl4-induced fibrotic HBV+ transgenic mice
Grace Bybee, Youra Moeun, Weimin Wang, Kusum K. Kharbanda, Larisa Y. Poluektova, Srivatsan Kidambi, Natalia A. Osna, Murali Ganesan
Frontiers in Immunology.2023;[Epub] CrossRef Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism
Hua-guo Feng, Chuan-xin Wu, Guo-chao Zhong, Jian-ping Gong, Chun-mu Miao, Bin Xiong
Journal of Cancer Research and Clinical Oncology.2023; 149(17): 15879. CrossRef Baseline metabolites could predict responders with hepatitis B virus-related liver fibrosis for entecavir or combined with FuzhengHuayu tablet
Yun-Kai Dai, Hai-Na Fan, Kai Huang, Xin Sun, Zhi-Min Zhao, Cheng-Hai Liu
World Journal of Hepatology.2023; 15(9): 1043. CrossRef Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Clinical and Molecular Hepatology.2023; 29(4): 851. CrossRef Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients
Yating Zhan, Qiqi Tao, Zhichao Lang, Lifan Lin, Xinmiao Li, Suhui Yu, Zhengping Yu, Guangyao Zhou, Kaifeng Wu, Zhenxu Zhou, Zhixian Yu, Jianjian Zheng
Journal of Medical Virology.2023;[Epub] CrossRef Interpreting Serogical Markers in Hepatitis B Virus Infection
Yasmeen Ahmed, Mohamed El-Kassas
Infectious Diseases in Clinical Practice.2023;[Epub] CrossRef Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC
Wanting Shi, Kang Li, Yonghong Zhang
Frontiers in Oncology.2023;[Epub] CrossRef Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(2): 288. CrossRef Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
Hira Hanif, Mukarram Jamat Ali, Ammu T Susheela, Iman Waheed Khan, Maria Alejandra Luna-Cuadros, Muzammil Muhammad Khan, Daryl Tan-Yeung Lau
World Journal of Gastroenterology.2022; 28(2): 216. CrossRef Potential Biomarkers for Liver Cancer Diagnosis Based on Multi-Omics Strategy
Fanghua Chen, Junming Wang, Yingcheng Wu, Qiang Gao, Shu Zhang
Frontiers in Oncology.2022;[Epub] CrossRef Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
Seunghwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Diagnostics.2022; 12(2): 441. CrossRef Highly Sensitive HBsAg, Anti-HBc and Anti HBsAg Titres in Early Diagnosis of HBV Reactivation in Anti-HBc-Positive Onco-Haematological Patients
Carlotta Cerva, Romina Salpini, Mohammad Alkhatib, Vincenzo Malagnino, Lorenzo Piermatteo, Arianna Battisti, Ada Bertoli, Jeff Gersch, Vera Holzmayer, Mary Kuhns, Gavin Cloherty, Ludovica Ferrari, Campogiani Laura, Elisabetta Teti, Maria Cantonetti, Willi
Biomedicines.2022; 10(2): 443. CrossRef Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study
Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2022; 29(4): 289. CrossRef Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients
Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim, Yeon Seok Seo
Journal of Clinical Medicine.2022; 11(6): 1729. CrossRef Application of Health Education Model Based on Theory of Behavior Change in Nursing Care of Patients with Chronic Hepatitis B
Ying Luo, Zhenhua Dong, Suying Qi, Weiguo Li
Journal of Nanomaterials.2022; 2022: 1. CrossRef KASL clinical practice guidelines for management of chronic hepatitis B
Clinical and Molecular Hepatology.2022; 28(2): 276. CrossRef Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
Claryssa Bianca, Elizabeth Sidhartha, Claudio Tiribelli, Korri Elvanita El-Khobar, Caecilia H C Sukowati
World Journal of Hepatology.2022; 14(5): 866. CrossRef Diagnostic Value of Combined Detection via Protein Induced by Vitamin K Absence or Antagonist II, Alpha-Fetoprotein, and D-Dimer in Hepatitis B Virus-Related Hepatocellular Carcinoma
Fang Peng, Hao Yuan, Yi-Feng Zhou, Si-Xian Wu, Zhen-Yi Long, Ya-Meng Peng
International Journal of General Medicine.2022; Volume 15: 5763. CrossRef Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
Yun-Kai Dai, Zhi-Min Zhao, Chenghai Liu
Frontiers in Pharmacology.2022;[Epub] CrossRef Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
Cancers.2022; 14(20): 5002. CrossRef Risk Predictive Model Based on Three DDR-Related Genes for Predicting Prognosis, Therapeutic Sensitivity, and Tumor Microenvironment in Hepatocellular Carcinoma
Renzhi Hu, Xiping Liang, Qiying Li, Yao Liu, Zhongjie Shi
Journal of Oncology.2022; 2022: 1. CrossRef Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
Wen-Qing Li, Wen-Hao Liu, Die Qian, Jia Liu, Shi-Qiong Zhou, Lei Zhang, Wei Peng, Li Su, Hong Zhang
Frontiers in Pharmacology.2022;[Epub] CrossRef Correlation of Serum M-CSF, CER, and TIMP-1 Levels with Liver Fibrosis in Viral Hepatitis
Hairong Yao, Xuan Yang, Man Yan, Xueqin Fang, Yange Wang, Hong Qi, Li Sun, Min Tang
Computational and Mathematical Methods in Medicine.2022; 2022: 1. CrossRef Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa
Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, Amie Ceesay, Ramou Njie, Bakary Sanneh, Ignatius Baldeh, Umberto D’Alessandro, Maimuna Mendy, Mark Thursz, Isabelle Chemin, Yasuhito Tanaka, Maud Lemoine, Yusuke Shimakawa
Journal of Global Health.2022;[Epub] CrossRef Response to Liao et al.
Byungyoon Yun, Jin-Ha Yoon, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(10): 1718. CrossRef Updated Treatment Guidelines for Chronic Hepatitis B
Jihyun An
The Korean Journal of Medicine.2022; 97(6): 353. CrossRef Diagnostic accuracy of mac‐2‐binding protein glycosylation isomer for diagnosing hepatitis B‐related fibrosis: A meta‐analysis
Ming Jian Lian, Zhi Qi Chen, Qian Ming Wang, Gang Sen Zheng, Guo Lin Hong
Journal of Digestive Diseases.2022; 23(10): 550. CrossRef Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
Hepatology International.2021; 15(5): 1083. CrossRef Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2021; 13(23): 5892. CrossRef The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B
Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef Hepatitis B Core-Related Antigen: From Virology to Clinical Application
Hye Won Lee, Sang Hoon Ahn, Henry Lik-Yuen Chan
Seminars in Liver Disease.2021; 41(02): 182. CrossRef The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection
Hiroyuki Amano, Tatsuo Kanda, Hitoshi Mochizuki, Yuichiro Kojima, Yoji Suzuki, Kenji Hosoda, Hiroshi Ashizawa, Yuko Miura, Shotaro Tsunoda, Yosuke Hirotsu, Hiroshi Ohyama, Naoya Kato, Mitsuhiko Moriyama, Shuntaro Obi, Masao Omata
Viruses.2021; 13(11): 2216. CrossRef Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma
Si-Young Kim, Hee-Seung Lee, Seung-Min Bang, Dai-Hoon Han, Ho-Kyoung Hwang, Gi-Hong Choi, Moon-Jae Chung, Seung-Up Kim
Cancers.2021; 13(8): 1828. CrossRef Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef Recent Advances in Hepatitis B Treatment
Georgia-Myrto Prifti, Dimitrios Moianos, Erofili Giannakopoulou, Vasiliki Pardali, John Tavis, Grigoris Zoidis
Pharmaceuticals.2021; 14(5): 417. CrossRef Efficacy and Safety of Tenofovir Disoproxil Orotate in Chronic Hepatitis B Patients Previously Treated with Tenofovir Disoproxil Fumarate: Multicenter, Open-Label, Prospective Study
Young Chang, Sang-Gyune Kim, Soung-Won Jeong, Jae-Young Jang, Jeong-Ju Yoo, Sae-Hwan Lee, Young-Seok Kim, Hong-Soo Kim, Hyun-Woong Lee, Suyeon Park
Journal of Clinical Medicine.2021; 10(23): 5628. CrossRef Another oral antiviral treatment, but still far away from hepatitis B virus cure
Tai-Chung Tseng
Clinical and Molecular Hepatology.2021; 27(2): 281. CrossRef Mac‐2 binding protein and its glycan isomer: Where does it come from? Where is it going?
Katsuya Nagaoka, Motohiko Tanaka, Yasuhito Tanaka
Hepatology Research.2021; 51(10): 1026. CrossRef Controversies in the Management of Hepatitis B
Stuart K. Roberts, Ammar Majeed, William Kemp
Clinics in Liver Disease.2021; 25(4): 785. CrossRef Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park
Journal of Viral Hepatitis.2021; 28(11): 1570. CrossRef Liver stiffness measured with two-dimensional shear wave elastography comparable to histopathology falls dominantly on the severe liver fibrosis
Ya Li, Size Wu
Clinical Hemorheology and Microcirculation.2021; 79(4): 587. CrossRef External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals
Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng
Clinical and Molecular Hepatology.2021; 27(4): 524. CrossRef Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins
Sanae Hayashi, Katsuya Nagaoka, Yasuhito Tanaka
International Journal of Molecular Sciences.2021; 22(20): 11051. CrossRef Association of the Hepatitis B Virus Large Surface Protein with Viral Infectivity and Endoplasmic Reticulum Stress-mediated Liver Carcinogenesis
Wei-Ling Lin, Jui-Hsiang Hung, Wenya Huang
Cells.2020; 9(9): 2052. CrossRef A Rapid Immunochromatographic Method Based on a Secondary Antibody-Labelled Magnetic Nanoprobe for the Detection of Hepatitis B preS2 Surface Antigen
Yangyang Cai, Jun Yan, Li Zhu, Hengliang Wang, Ying Lu
Biosensors.2020; 10(11): 161. CrossRef Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers
Romina Salpini, Vincenzo Malagnino, Lorenzo Piermatteo, Tiziana Mulas, Mohammad Alkhatib, Rossana Scutari, Elisabetta Teti, Carlotta Cerva, Katia Yu La Rosa, Marta Brugneti, Ada Bertoli, Benedetta Rossi, Vera Holzmayer, Jeffrey Gersch, Mary Kuhns, Gavin C
Microorganisms.2020; 8(11): 1819. CrossRef
|